Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
R&D Systems™ Recombinant Human EGF Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Supplier: R&D Systems™ 236EG01M
This item is not returnable.
View return policy
Description
Measured in a cell proliferation assay using Balb/3T3 mouse embryonic fibroblast cells. Rubin, J.S. et al. (1991) Proc. Natl. Acad. Sci. USA 88:415. The ED50 for this effect is 20-100 pg/mL.Specifications
P01133 | |
Lyophilized from a 0.2 μm filtered solution in PBS. | |
M.W. (Observed): 6 kDa, reducing conditions; M.W. (theoretical): 6 kDa | |
1 mg | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. | |
EGF | |
Recombinant | |
>97%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining. |
Bioactivity | |
1950 | |
EGF | |
E. coli-derived human EGF protein Asn971-Arg1023, with an N-terminal Met | |
<0.10 EU / 1 μg of the protein by the LAL method. | |
Unconjugated | |
Reconstitute at 500 μg/mL in sterile PBS. | |
EGF |
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?
Provide Content Correction